NO974728L - Polyoksyetylen som har en sukker i en ende og en ulik funksjonell gruppe i den andre enden, og en fremgangsmåte for fremstilling - Google Patents

Polyoksyetylen som har en sukker i en ende og en ulik funksjonell gruppe i den andre enden, og en fremgangsmåte for fremstilling

Info

Publication number
NO974728L
NO974728L NO974728A NO974728A NO974728L NO 974728 L NO974728 L NO 974728L NO 974728 A NO974728 A NO 974728A NO 974728 A NO974728 A NO 974728A NO 974728 L NO974728 L NO 974728L
Authority
NO
Norway
Prior art keywords
denotes
polymer
oligomer
functional group
sugar
Prior art date
Application number
NO974728A
Other languages
English (en)
Other versions
NO974728D0 (no
Inventor
Masao Kato
Yukio Nagasaki
Teruo Nakamura
Teruo Okano
Original Assignee
Kataoka Kazunori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kataoka Kazunori filed Critical Kataoka Kazunori
Publication of NO974728D0 publication Critical patent/NO974728D0/no
Publication of NO974728L publication Critical patent/NO974728L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C08G65/2606—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Polyethers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO974728A 1995-04-14 1997-10-13 Polyoksyetylen som har en sukker i en ende og en ulik funksjonell gruppe i den andre enden, og en fremgangsmåte for fremstilling NO974728L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8937395 1995-04-14
PCT/JP1996/001020 WO1996032434A1 (en) 1995-04-14 1996-04-12 Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same

Publications (2)

Publication Number Publication Date
NO974728D0 NO974728D0 (no) 1997-10-13
NO974728L true NO974728L (no) 1997-12-05

Family

ID=13968897

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974728A NO974728L (no) 1995-04-14 1997-10-13 Polyoksyetylen som har en sukker i en ende og en ulik funksjonell gruppe i den andre enden, og en fremgangsmåte for fremstilling

Country Status (20)

Country Link
US (2) US5973069A (no)
EP (1) EP0852243B1 (no)
JP (1) JP4036472B2 (no)
KR (1) KR19990007804A (no)
CN (1) CN1085690C (no)
AT (1) ATE226966T1 (no)
AU (1) AU5289096A (no)
BR (1) BR9604895A (no)
CA (1) CA2218140A1 (no)
DE (1) DE69624581T2 (no)
DK (1) DK0852243T3 (no)
ES (1) ES2185769T3 (no)
HU (1) HU221090B1 (no)
MX (1) MX9707887A (no)
NO (1) NO974728L (no)
NZ (1) NZ304991A (no)
PT (1) PT852243E (no)
RU (1) RU2193574C2 (no)
SI (1) SI9620064A (no)
WO (1) WO1996032434A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861459B2 (en) * 1999-07-09 2005-03-01 Construction Research & Technology Gmbh Oligomeric dispersant
US6133347A (en) * 1999-07-09 2000-10-17 Mbt Holding Ag Oligomeric dispersant
US6908955B2 (en) * 1999-07-09 2005-06-21 Construction Research & Technology Gmbh Oligomeric dispersant
JP2001048978A (ja) 1999-08-04 2001-02-20 Nano Career Kk オキサゾリン由来のポリマーセグメントを有するブロックコポリマー
JP2001208754A (ja) * 2000-01-26 2001-08-03 Kazunori Kataoka 生物学的な被検体を検出するための組成物
JP2001247591A (ja) * 2000-03-02 2001-09-11 Natl Inst Of Advanced Industrial Science & Technology Meti 重合性グルコフラノース誘導体およびその製造方法
AU5667901A (en) * 2000-05-11 2001-11-20 Center For Advanced Science And Technology Incubation, Ltd. Polymer composition for forming surface of biosensor
JP4063510B2 (ja) * 2001-07-13 2008-03-19 ナノキャリア株式会社 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤
ATE406436T1 (de) 2001-07-26 2008-09-15 Transparent Inc Konstrukt aus kultivierten zellen mit spheroiden von kultivierten tierzellen und verwendung davon
DE60223047T2 (de) 2001-08-22 2008-07-24 Bioartificial Gel Technologies Inc., Montreal Verfahren zur herstellung von aktivierten polyethylenglykolen
EP1489415A4 (en) 2002-03-11 2006-02-22 Toudai Tlo Ltd BRUSH-LIKE STRUCTURED SURFACE OF POLYETHYLENE OXIDE WITH INCREASED DENSITY
JP4555678B2 (ja) * 2002-05-08 2010-10-06 メディカル エンザイムズ アクチエンゲゼルシャフト 化学修飾のための活性糖質含有保護試薬、その製造及び使用
WO2005073370A1 (ja) * 2004-01-31 2005-08-11 Transparent Inc. 酵素複合体
US7351787B2 (en) * 2004-03-05 2008-04-01 Bioartificial Gel Technologies, Inc. Process for the preparation of activated polyethylene glycols
DK2656840T3 (en) 2005-06-09 2015-11-02 Nanocarrier Co Ltd Process for preparing polymerized platinum complex coordination compounds
WO2007099660A1 (ja) 2006-03-01 2007-09-07 The University Of Tokyo 核酸内包高分子ミセル複合体
JPWO2007102608A1 (ja) * 2006-03-06 2009-07-23 ナノキャリア株式会社 疎水性化合物の安定化剤
CA2650422A1 (en) * 2006-04-24 2007-11-08 Nanocarrier Co., Ltd. Process for producing polymer micelles encapsulating low molecular weight drugs
CN101489574A (zh) 2006-07-18 2009-07-22 那野伽利阿株式会社 内包生理活性多肽或蛋白质的高分子聚合物胶束及其制造方法
WO2008062909A1 (en) 2006-11-22 2008-05-29 The University Of Tokyo ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE
US20080161535A1 (en) * 2006-12-21 2008-07-03 Wiggins Michael S Thickening and wetting agents
EP2164878A1 (en) * 2007-07-12 2010-03-24 Basf Se Nitrocellulose based dispersant
US8075909B2 (en) 2007-09-04 2011-12-13 University Of Florida Research Foundation, Incorporated Contact lens based bioactive agent delivery system
US20110060123A1 (en) 2008-04-30 2011-03-10 Kazunori Kataoka Charge conversional ternary polyplex
DK2305275T3 (da) 2008-06-24 2013-10-07 Nanocarrier Co Ltd Væskesammensætning omfattende cisplatinkoordinerende forbindelse
CA2728960C (en) 2008-06-26 2016-04-12 Japan Science And Technology Agency Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same
TW201120063A (en) * 2009-08-21 2011-06-16 Idemitsu Kosan Co Sugar derivative having a polymerizable group, and resist material using said sugar derivative
US20110081293A1 (en) 2009-10-07 2011-04-07 Sanford-Burnham Medical Research Institute Methods and compositions related to clot-binding lipid compounds
JP4829351B2 (ja) 2010-02-05 2011-12-07 ナノキャリア株式会社 易崩壊型ポリマーミセル組成物
WO2011127405A1 (en) 2010-04-08 2011-10-13 Sanford-Burnham Medical Research Institute Methods and compositions for enhanced delivery of compounds
EP2572780B1 (en) 2010-05-21 2018-07-11 Japan Science And Technology Agency Vesicles with encapsulated substance and production method therefor
EP2591792B1 (en) 2010-07-09 2016-12-21 The University of Tokyo Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
RU2538211C2 (ru) * 2012-09-12 2015-01-10 Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук Способ получения углеводсодержащих полимеров
CN109663550B (zh) 2013-03-01 2021-08-06 国立研究开发法人科学技术振兴机构 物质包封微囊及其制备方法
WO2014157150A1 (ja) * 2013-03-25 2014-10-02 日油株式会社 ベンジリデンアセタールリンカーを有する親水性ポリマー誘導体
CN105377302B (zh) 2013-05-17 2018-05-11 那野伽利阿株式会社 聚合物胶束医药组合物
JP2015046867A (ja) 2013-07-31 2015-03-12 株式会社リコー 撮像装置
WO2015020026A1 (ja) 2013-08-06 2015-02-12 独立行政法人科学技術振興機構 核酸内包高分子ミセル複合体及びその製造方法
EP3037107B1 (en) 2013-08-23 2019-10-09 The University of Tokyo Polymer nanoparticle composite and composition for mri imaging including same
JP5971264B2 (ja) 2014-01-10 2016-08-17 Ｊｆｅスチール株式会社 極厚肉油井管用ねじ継手
US10500246B2 (en) 2015-06-25 2019-12-10 Sanford Burnham Prebys Medical Discovery Institute Compositions for delivery to and treatment of atherosclerotic plaques
DE102017003004A1 (de) * 2017-03-23 2018-09-27 Friedrich-Schiller-Universität Jena Kationische Polymere mit D-Fructose-Substituenten
WO2018204392A1 (en) 2017-05-02 2018-11-08 Stanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
WO2020161602A1 (en) 2019-02-04 2020-08-13 University Of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
EP3808757A1 (en) 2019-10-14 2021-04-21 École Polytechnique Fédérale de Lausanne (EPFL) Renewable monomer and polymer thereof
CN112029084B (zh) * 2020-08-31 2021-10-26 华南理工大学 一种以硫代羧酸为引发剂简便、可控合成α-巯基-ω-羟基聚醚的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163056D1 (en) * 1980-06-20 1984-05-17 Goldschmidt Ag Th Process for the production of polymers with at least one terminal primary hydroxyl group
EP0154316B1 (en) * 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
GB8427886D0 (en) * 1984-11-03 1984-12-12 Manchester Inst Science Tech Formation of polyols
JPS61152393A (ja) * 1984-12-26 1986-07-11 株式会社日立製作所 複合材の切断方法および切断金型
US5037969A (en) * 1986-07-03 1991-08-06 Takeda Chemical Industries, Ltd. Glycosyl derivatives and use thereof
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
EP0442804B1 (fr) * 1990-02-14 1996-08-28 Elf Atochem S.A. Macromonomères multiséquencés fonctionnalisés et leur procédé de fabrication
DE4039193A1 (de) * 1990-12-08 1992-06-11 Bayer Ag In wasser dispergierbare, elektrolytstabile polyetherester-modifizierte polyurethanionomere
WO1992004048A2 (en) * 1990-08-30 1992-03-19 The Biomembrane Institute Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
JP2593032B2 (ja) * 1992-02-07 1997-03-19 新技術事業団 両末端ヘテロ官能性ポリエーテル並びに該ポリエーテルを製造する方法及び重合開始剤
DE4313117C2 (de) * 1993-04-22 1995-09-28 Grillo Werke Ag Fettsäureester von Methylglukosid-Derivaten, Verfahren zu ihrer Herstellung und Verwendung
DE4317231A1 (de) * 1993-05-24 1994-12-01 Wolff Walsrode Ag Thermoplastische Celluloseetherester-Mischpfropfpolymerisate und Verfahren zu ihrer Herstellung
JP3465307B2 (ja) * 1993-08-05 2003-11-10 日本油脂株式会社 ポリアルキレンオキシド誘導体および製造方法
JP3407397B2 (ja) * 1994-05-06 2003-05-19 日本油脂株式会社 ポリオキシアルキレン誘導体および製造方法
JP3508207B2 (ja) * 1994-05-30 2004-03-22 日本油脂株式会社 ポリオキシアルキレン誘導体の製造方法
JP3508234B2 (ja) * 1994-09-22 2004-03-22 日本油脂株式会社 ポリオキシアルキレン誘導体の製造方法

Also Published As

Publication number Publication date
DE69624581T2 (de) 2003-05-15
DK0852243T3 (da) 2003-02-24
US6090317A (en) 2000-07-18
AU5289096A (en) 1996-10-30
WO1996032434A1 (en) 1996-10-17
SI9620064A (sl) 1998-06-30
DE69624581D1 (de) 2002-12-05
EP0852243B1 (en) 2002-10-30
CN1085690C (zh) 2002-05-29
HUP9801120A3 (en) 1998-12-28
PT852243E (pt) 2003-03-31
NZ304991A (en) 2000-02-28
KR19990007804A (ko) 1999-01-25
HUP9801120A2 (hu) 1998-08-28
EP0852243A4 (en) 1998-08-26
JP4036472B2 (ja) 2008-01-23
RU2193574C2 (ru) 2002-11-27
CA2218140A1 (en) 1996-10-17
EP0852243A1 (en) 1998-07-08
ATE226966T1 (de) 2002-11-15
BR9604895A (pt) 1999-11-30
MX9707887A (es) 1997-11-29
HU221090B1 (en) 2002-08-28
ES2185769T3 (es) 2003-05-01
CN1187212A (zh) 1998-07-08
NO974728D0 (no) 1997-10-13
US5973069A (en) 1999-10-26

Similar Documents

Publication Publication Date Title
NO974728D0 (no) Polyoksyetylen som har en sukker i en ende og en ulik funksjonell gruppe i den andre enden, og en fremgangsmåte for fremstilling
KR940003969A (ko) 피이지(peg)- 인터페론 결합체
BG102100A (bg) Методи за получаване на мономерни конюгати калихеамициново производно/носител
NO974678D0 (no) Heterotelechelisk blokk-kopolymer og en fremgangsmåte for fremstilling derav
CA2189271A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
MD1315B1 (en) Oxim esters and intermediate compositions, process for preparation thereof, compositions, process for pests control.
CA2174033A1 (fr) Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
EA200100533A1 (ru) Производные эритромицина, способ их получения и их применение в качестве лекарственных средств
EP0193148A3 (en) 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(alkoxy-containing acyl)hydrazides
AR010307A1 (es) Derivado de la eritromicina a, composicion farmaceutica y preparacion antibacteriana que lo contienen.
GR3025268T3 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
DE50108530D1 (de) Verfahren zur Herstellung von Aminoalkylsilanen
DE69921151D1 (de) Fluorszierende marker
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
KR890016009A (ko) 1,2,5,6-테트라히드로 피리딘유도체, 이들의 제조방법, 의약으로서 이들의 용도 및 이들을 함유하는 조성물
IL69881A (en) 1-pyridinyl(or tetrahydropyridinyl)-3-phenyl indenes,their preparation and pharmaceutical compositions comprising them
HU906230D0 (en) Process for the preparation of benzanilide derivatives and medical preparations containing them
ATE121723T1 (de) Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen.
EP0298423A3 (en) Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same
EA199900528A1 (ru) Новые производные эритромицина, способ их получения и применения в качетве медикаментов
EA200000530A1 (ru) НОВЫЕ 19-НОРСТЕРОИДЫ, ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 11β, СПОСОБ И ПРОМЕЖУТОЧНЫЕ ПРОДУКТЫ ДЛЯ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
KR890005039A (ko) 시아노 아세트 아미드 유도체, 그의 제조방법 및 그것을 유효 성분으로 함유하는 식물병 예방제
EP0297621A3 (en) Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application